Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Relationship between mean CagriSema dose and weight loss in the REDEFINE 1 trial

Authors :

W. Timothy Garvey¹; Jaime Almandoz²; Mikkel Hovden Christensen³; Cynthia Karenina Osorto Contreras³; Anthony N. Fabricatore⁴; Thomas Bo Jensen³; Michael G. Knight5, Kirsi H. Pietiläinen^6,7; Carel W. le Roux^8,9

Affiliations

View Details Hide Details

Download the poster (.pdf)

Keywords

Obesity

Congress short oral presentation

Amylin

CagriSema

PHASE 3 (RCT)